Moderna, Inc. (MRNA) Most Active Options

The 25 most actively traded Moderna, Inc. (MRNA) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$139.74
52-week range
$22.35 – $174.64
ATM IV (30d)
92.5%
IV rank
81 / 100
High
Expected move
±$33.83 (±24.2%)
Put/call OI
1.60
Put-heavy
Max pain
$95
↓ 32.0% below close
Next earnings
Nov 4, 2026

Most Active MRNA Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
MRNA $110 put Aug 28, 2026 4d $0.28 500.0% 100 0.00 8,348 11,136 41.7× avg
MRNA $130 put Aug 28, 2026 4d $3.40 121.3% 79 -0.28 2,320 7,210 18.9× avg
MRNA $200 call Aug 28, 2026 4d $0.22 166.1% 36 0.02 5,680 5,571 25.8× avg
MRNA $100 put Aug 28, 2026 4d $0.09 46 10,271 5,351 28.6× avg
MRNA $140 call Aug 28, 2026 4d $6.75 126.9% 93 0.50 3,535 5,036 4.0× avg
MRNA $150 call Aug 28, 2026 4d $3.52 132.8% 95 0.31 3,934 4,162 3.0× avg
MRNA $120 put Aug 28, 2026 4d $0.97 122.8% 81 -0.12 3,698 3,159 8.3× avg
MRNA $165 call Oct 16, 2026 53d $10.10 89.7% 77 0.37 1,040 2,847 37.8× avg
MRNA $125 put Aug 28, 2026 4d $1.95 120.2% 78 -0.19 1,419 2,647 7.0× avg
MRNA $160 call Aug 28, 2026 4d $1.77 136.6% 98 0.18 1,433 2,508 1.8× avg
MRNA $155 call Oct 16, 2026 53d $12.60 87.9% 79 0.44 182 2,493 38.2× avg
MRNA $130 call Oct 16, 2026 53d $22.85 87.9% 89 0.65 127 2,377 71.6× avg
MRNA $45 put Jan 15, 2027 144d $0.56 41 14,475 2,286 39.9× avg
MRNA $120 put Sep 18, 2026 25d $4.60 100 9,095 2,210 35.8× avg
MRNA $140 put Aug 28, 2026 4d $7.85 125.3% 89 -0.50 2,380 2,119 7.0× avg
MRNA $200 call Sep 18, 2026 25d $1.98 105.6% 45 0.12 1,405 2,050 38.6× avg
MRNA $20 put Jan 15, 2027 144d $0.06 55 11,340 2,014 35.2× avg
MRNA $170 call Aug 28, 2026 4d $1.02 146.7% 37 0.11 1,200 1,987 8.4× avg
MRNA $90 put Aug 28, 2026 4d $0.03 0.0% 0 1.00 10,540 1,977 11.1× avg
MRNA $135 put Aug 28, 2026 4d $5.23 122.9% 90 -0.39 610 1,850 3.3× avg
MRNA $260 call Aug 28, 2026 4d $0.02 209.2% 46 0.00 3,533 1,716 7.9× avg
MRNA $145 call Aug 28, 2026 4d $4.90 128.7% 96 0.40 3,119 1,611 1.3× avg
MRNA $255 call Aug 28, 2026 4d $0.03 207.0% 45 0.00 152 1,511 7.0× avg
MRNA $160 call Sep 18, 2026 25d $7.00 97.2% 63 0.34 612 1,470 21.3× avg
MRNA $138 call Aug 28, 2026 4d $7.68 126.7% 93 0.54 84 1,430 2.8× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active MRNA contract today is the $110 put expiring in 4 days, with 11,136 contracts traded. Calls dominate the most-active list (14 of the top 25), showing where trading interest concentrates. 21 of these contracts are running well ahead of the usual daily volume.

Explore the payoff profile of option on MRNA for free

Build multi-leg MRNA strategies, visualize payoffs, and scan the full US options universe with OptiView.

MRNA Options FAQ

Which MRNA option contract is most active today?

The most traded MRNA contract is the $110 put expiring Aug 28, 2026, with 11,136 contracts traded as of Aug 24, 2026.

How does OptiView rank the most active MRNA options?

The table lists the 25 MRNA contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.